ALS Intermediate Expanded Access
AI summary
This program supports scientific research using data from intermediate-size patient population expanded access protocols for amyotrophic lateral sclerosis.
Generated by AI from the funder’s public info. Double-check details before applying.
What this grant funds
The National Institute of Neurological Disorders and Stroke (NINDS) is interested in supporting the conduct of…
Who is eligible
- State governments
- Federally recognized Native American tribal governments
- County governments
- City or township governments
- Special district governments
- And 8 more applicant types (see More federal details)
Three steps to apply
Register in SAM.gov and Grants.gov. Federal applications need a UEI and an active SAM.gov registration. Registration can take several weeks.
Register in SAM.gov and Grants.gov
Federal applications need a UEI and an active SAM.gov registration. Registration can take several weeks.
Read the full announcement
Opportunity RFA-NS-28-009. It lists eligibility, budget rules and review criteria.
Watch for the listing to post
Forecasts can't take applications yet. Track this grant to hear when it posts.
Who’s behind it
Part of the Department of Health and Human Services. Federal grant-making agency listed on Grants.gov.
- Type
- Federal government
National Institutes of Health
Federal governmentMore federal details
Status, funding, applicant types, documents and assistance listings from the official listing.
Status & key dates
- ForecastMar 1, 2027
- Expected to postMar 1, 2027
- Estimated closeMay 25, 2027
- ArchiveNot set
Forecast dates are the agency's estimates and can change when the listing posts.
Funding
Eligible applicant types
Government
- State governments
- Federally recognized Native American tribal governments
- County governments
- City or township governments
- Special district governments
Nonprofit
- Nonprofits without 501(c)(3) status
- Nonprofits with 501(c)(3) status
- Other Native American tribal organizations
Education
- Private institutions of higher education
- Public and state institutions of higher education
Business
- For-profit organizations other than small businesses
- Small businesses
Other
- Other (see additional eligibility)
Additional eligibility
Eligible applicants must be clinical trial sites that participate in a phase 2/3 or phase 3 efficacy clinical trial (designed to provide pivotal data to establish substantial evidence of effectiveness in support of a marketing application) supported by a U.S. based small business concern that is the FDA-designated sponsor of a drug or biological product which is the subject of an IND under section 505(i) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(i)) to prevent, diagnose, mitigate, treat, or cure ALS. The definition of a small business concern can be found in section 3(a) of the Small Business Act (15 U.S.C. 632(a)).Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Agency contact
Assistance listings
Source: Simpler.Grants.gov listing, version 1 · checked Nov 22, 2026
More from National Institutes of Health
Keep every grant in one place
Save grants, track deadlines and get reminders.